Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions
2008

Gene expression profiling of human prostate cancer stem cells

Sample size: 19 publication 10 minutes Evidence: moderate

Author Information

Author(s): Richard Birnie, Steven D. Bryce, Claire Roome, Vincent Dussupt, Alastair Droop, Shona H. Lang, Paul A. Berry, Catherine F. Hyde, John L. Lewis, Michael J. Stower, Norman J. Maitland, Anne T. Collins

Primary Institution: Pro-Cure Therapeutics Ltd, University of York, Hull York Medical School, York Centre for Complex Systems Analysis, York Hospital

Hypothesis

The study investigates the gene expression signature of human prostate cancer stem cells and its implications for understanding their biology.

Conclusion

The study identifies an expression signature of 581 genes in prostate cancer stem cells, highlighting the importance of the JAK-STAT pathway and focal adhesion signaling.

Supporting Evidence

  • The study identified 581 differentially expressed genes in prostate cancer stem cells.
  • Functional studies indicated that NF-κB inhibition preferentially induced apoptosis in cancer stem cells.
  • Key pathways identified include JAK-STAT signaling and focal adhesion signaling.

Takeaway

Researchers looked at special cells in prostate cancer that help tumors grow and found important genes that could help us understand and treat the disease better.

Methodology

The study used Affymetrix gene-expression arrays to analyze RNA from sorted cell populations and validated findings with quantitative RT-PCR, flow cytometry, and immunocytochemistry.

Potential Biases

Potential bias may arise from the selection of specific cell populations and the exclusion of certain tumor grades.

Limitations

The study excluded certain samples, such as Gleason 6 tumors and hormone-refractory samples, which may limit the generalizability of the findings.

Participant Demographics

The study involved 12 patients with prostate cancer and 7 patients with benign prostatic hyperplasia, aged 52-79.

Statistical Information

P-Value

p<0.035

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/gb-2008-9-5-r83

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication